SFX by Ex Libris Inc.

Title:	Recognition of unique carboxyl-terminal motifs by distinct PDZ domains
Source:	Science [0036-8075] Songyang, Z yr:1997

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sheng, M.. "PDZ DOMAINS AND THE ORGANIZATION OF SUPRAMOLECULAR COMPLEXES." Annual Review of Neuroscience 24.1 (2001): 1-29.
description	2.	Sicheri, F. "Structures of Src-family tyrosine kinases." Current opinion in structural biology 7.6 (1998): 777-85.
description	3.	Yaffe, M. "The structural basis for 14-3-3 : phosphopeptide binding specificity." Cell 91.7 (1997): 961-971.
description	4.	Campbell, Duncan J J. "Can measurement of B-type natriuretic Peptide levels improve cardiovascular disease prevention?" Clinical and experimental pharmacology & physiology 35.4 (2008): 442-6.
description	5.	Doyle, R. "Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ." Cell 85.7 (1996): 1067-76.
description	6.	Gouliaev, A H H. "Piracetam and other structurally related nootropics." Brain Research Reviews 19.2 (1994): 180-222.
description	7.	Karin, M. "Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6." Nature 439.7073 (2005): 204-7.
description	8.	Sheng, M. "PDZ domain proteins of synapses." Nature reviews. Neuroscience 5.10 (2004): 771-81.
description	9.	Arnold, F. "Combinatorial and computational challenges for biocatalyst design." Nature 409.6817 (2001): 253-257.
description	10.	Kay, B K K. "The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains." The FASEB journal 14.2 (2000): 231-41.
description	11.	Wozakowska-Kapłon, B. "[Natriuretic peptides in atrial fibrillation. State of art and new concepts]." Kardiologia polska (2004): 154-157.
description	12.	Tzivion, G. "14-3-3 proteins: Active cofactors in cellular regulation by serine/threonine phosphorylation." The Journal of biological chemistry 277.5 (2002): 3061-3064.
description	13.	Grzesiek, S. "The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase." Nature structural biology 3.4 (1996): 340-345.
description	14.	;. "Stat Bite:U.S. Cancer Death Rates by Race." Journal of the National Cancer Institute 100.5 (2008): 297-297.
description	15.	Zha, J. "Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)." Cell 87.4 (1996): 619-28.
description	16.	Yamaguchi, H. "Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation." Nature 384.6608 (1996): 484-489.
description	17.	Fritsky, Roland O. "An allosteric synthetic catalyst: Metal ions tune the activity of an artificial phosphodiesterase." Chemistry 7.6 (2001): 1221-1231.
description	18.	Wiedemann, U. "Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of superbinding peptides." Journal of molecular biology 343.3 (2004): 703-718.
description	19.	Gohla, A. "14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin." Current biology 12.19: 1704-1710.
description	20.	Harrison, S C C. "Peptide-surface association: the case of PDZ and PTB domains." Cell 86.3 (1996): 341-3.